Acetic Acid
A dilute sterile acetic acid solution (typically 0.6%) used to dissolve certain peptides that don't dissolve well in plain water at neutral pH. Required specifically for peptides that need acidic conditions to dissolve. Only used when the peptide manufacturer specifically recommends acetic acid reconstitution — most peptides should use bacteriostatic water instead.
Dosage
Not applicable — reconstitution supply
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Used to dissolve/reconstitute specific peptides for injection
Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Mechanism of Action
Sterile acetic acid solution is not a therapeutic agent — it is a reconstitution solvent used when specific peptides require acidic conditions to dissolve properly. At the typical 0.6% concentration (pH approximately 3.5-4.0), it provides a mildly acidic aqueous environment that addresses solubility challenges faced by certain peptides in neutral pH water.
The need for acetic acid arises from the physicochemical properties of peptides with basic isoelectric points (pI). A peptide's solubility is lowest at its isoelectric point, where the net charge is zero and intermolecular attractions (hydrophobic interactions, hydrogen bonding between uncharged residues) can cause aggregation and precipitation. Many growth hormone-releasing peptides and antimicrobial peptides have basic pI values (above pH 7), meaning they carry minimal net charge at neutral pH and tend to aggregate in bacteriostatic water (pH ~5.5-7). Dissolving these peptides in acetic acid solution lowers the pH well below their pI, protonating basic residues (lysine, arginine, histidine) and giving the peptide a strong positive net charge. Like-charged molecules repel each other electrostatically, preventing aggregation and maintaining a clear, homogeneous solution.
The 0.6% concentration is a balance between sufficient acidity for solubilization and minimal tissue irritation upon injection. Higher concentrations would provide better solubilization but cause more stinging at the injection site. Acetic acid is preferred over hydrochloric acid because it is a weak acid that provides buffering capacity, maintaining a more stable pH. Not all peptides require acetic acid reconstitution — most dissolve adequately in bacteriostatic water — so it should only be used when specifically indicated by the peptide manufacturer or when visible precipitation occurs with standard reconstitution.
Regulatory Status
Pharmaceutical-grade sterile acetic acid available through medical supply companies. Not a regulated drug product.
Risks & Safety
Common
stinging and burning at injection site due to acidity.
Serious
tissue damage if used at improper concentration, peptide damage if used with peptides that do not require acidic pH.
Rare
injection site tissue damage with highly concentrated solutions.
Research Papers
31Published: February 1, 2026
AI Summary
Abstract too short to summarize.
Published: February 10, 2026
AI Summary
Levetiracetam reduced amyloid production in Alzheimer's models by shifting APP processing away from the amyloidogenic pathway in an SV2a-dependent manner. The drug may help prevent amyloid buildup before irreversible damage occurs.
Published: March 19, 2026
AI Summary
A correction equation improved transfer of peptide purification methods from HPLC to FPLC, reducing errors. Using formic acid instead of trifluoroacetic acid offered a greener option with improved separation.
Published: February 1, 2026
AI Summary
A yeast-LAB consortium improved sweet sorghum silage quality by boosting lactic acid and acetic acid while reducing fiber and ammonia. The approach may enhance biomass silage quality.
Published: February 19, 2026
AI Summary
Abstract too short to summarize.
Published: January 21, 2026
AI Summary
Ginsenoside Rb3 relieved colitis in mice by reshaping gut bacteria and raising acetic and butyric acid levels. The compound improved the gut barrier and reduced inflammation.
Published: March 5, 2026
AI Summary
Abstract too short to summarize.
Published: December 30, 2026
AI Summary
A bacterial exopolysaccharide lowered cholesterol in mice by enriching Muribaculum and activating the FXR-FGF15 axis. The bacterium also increased intestinal acetic and caproic acid.
Published: January 19, 2026
AI Summary
Combining acetic acid and exercise restored mitochondrial function in muscle of ovariectomized mice; neither alone was sufficient. The finding may inform interventions for metabolic decline after menopause.
Published: January 19, 2026
AI Summary
Plant-based fermented foods may improve blood sugar through organic acids, microbial metabolites, and slower digestion. Human effects are modest and context-dependent; natto and some kombucha show the strongest signals.
Published: January 26, 2026
AI Summary
Disc and bone degeneration in a rat model correlated with chronic low back pain through structural changes and nerve sensitization. Targeting both tissues may help treat degenerative spine pain.
Published: February 7, 2026
AI Summary
A new method using EDTA improved glyphosate and AMPA detection in groundwater with hard water. The approach achieved reliable quantification across varied conditions.
Published: February 9, 2026
AI Summary
Abstract too short to summarize.
Published: January 16, 2026
AI Summary
Abstract too short to summarize.
Published: April 5, 2026
AI Summary
Abstract too short to summarize.
Published: January 31, 2026
AI Summary
High-fat diet worsened milk allergy in mice by raising Staphylococcus and histidine levels. The findings may inform prevention of diet-exacerbated food allergy.
Published: November 8, 2025
AI Summary
Triptolide and methotrexate together reduced inflammation in macrophages by suppressing the cGAS-STING pathway. The combination may help treat rheumatoid arthritis.
Published: January 5, 2026
AI Summary
Abstract too short to summarize.
Published: September 2, 2026
AI Summary
Abstract too short to summarize.
Published: December 15, 2025
AI Summary
Abstract too short to summarize.
Published: December 29, 2025
AI Summary
Rumen microbiota-derived indole-3-acetic acid supported gut barrier function in peripartum cows through AhR signaling. Restoring this pathway may help prevent metabolic disorders.
Published: January 23, 2026
AI Summary
Wine and vinegar showed different protease activities: cysteine protease dominated in wine, aspartic protease in vinegar. The work clarifies proteolytic activity in fermented grape products.
Published: December 14, 2025
AI Summary
Beaucarnea recurvata leaf extract reduced ulcerative colitis in rats by lowering oxidative stress and inflammation. The extract may offer a multi-target option for colitis.
Published: December 11, 2025
AI Summary
Yeast lacking NatB N-terminal acetyltransferase were more sensitive to acetic acid when expressing Bax. The findings may inform treatments for cell death disorders.
Published: December 11, 2025
AI Summary
Saroglitazar reduced liver injury in rats by blocking TXNIP and NLRP3 inflammasome activation. The drug may help treat inflammatory liver disease in patients with diabetes.
Published: February 25, 2026
AI Summary
Abstract too short to summarize.
Published: December 25, 2025
AI Summary
An engineered E. coli strain with pka and arcA deletions reduced acetate overflow and increased recombinant protein production. The strain may be useful for industrial bioprocessing.
Published: December 11, 2025
AI Summary
Abstract too short to summarize.
Published: December 22, 2025
AI Summary
A peptide-compound conjugate with 2-isopropyl-5-methylphenoxy acetic acid reduced inflammation and bacterial growth by blocking NF-κB/MAPK signaling. The compound may help treat lung injury from endotoxin.
Published: September 24, 2025
AI Summary
Abstract too short to summarize.
Published: March 31, 2026
AI Summary
A composite coagulant reduced disinfection by-products from algae, including trichloroacetic and dichloroacetic acid precursors. The approach may improve water supply safety.
Frequently Asked Questions
What is Acetic Acid?
A dilute sterile acetic acid solution (typically 0.6%) used to dissolve certain peptides that don't dissolve well in plain water at neutral pH. Required specifically for peptides that need acidic conditions to dissolve. Only used when the peptide manufacturer specifically recommends acetic acid reconstitution — most peptides should use bacteriostatic water instead.
What is Acetic Acid used for?
A dilute sterile acetic acid solution (typically 0.6%) used to dissolve certain peptides that don't dissolve well in plain water at neutral pH. Required specifically for peptides that need acidic conditions to dissolve. Only used when the peptide manufacturer specifically recommends acetic acid reconstitution — most peptides should use bacteriostatic water instead.
What is the dosage for Acetic Acid?
Reconstitution supply: used only when peptide manufacturer instructions specifically call for acetic acid reconstitution. Typical 0.6% sterile solution. Same slow injection technique as bacteriostatic water — inject against the vial wall.
What are the side effects of Acetic Acid?
Common: stinging and burning at injection site due to acidity. Serious: tissue damage if used at improper concentration, peptide damage if used with peptides that do not require acidic pH. Rare: injection site tissue damage with highly concentrated solutions.
How does Acetic Acid work?
Sterile acetic acid solution is not a therapeutic agent — it is a reconstitution solvent used when specific peptides require acidic conditions to dissolve properly. At the typical 0.6% concentration (pH approximately 3.5-4.0), it provides a mildly acidic aqueous environment that addresses solubility challenges faced by certain peptides in neutral pH water. The need for acetic acid arises from the physicochemical properties of peptides with basic isoelectric points (pI). A peptide's solubility is lowest at its isoelectric point, where the net charge is zero and intermolecular attractions (hydrophobic interactions, hydrogen bonding between uncharged residues) can cause aggregation and precipitation. Many growth hormone-releasing peptides and antimicrobial peptides have basic pI values (above pH 7), meaning they carry minimal net charge at neutral pH and tend to aggregate in bacteriostatic water (pH ~5.5-7). Dissolving these peptides in acetic acid solution lowers the pH well below their pI, protonating basic residues (lysine, arginine, histidine) and giving the peptide a strong positive net charge. Like-charged molecules repel each other electrostatically, preventing aggregation and maintaining a clear, homogeneous solution. The 0.6% concentration is a balance between sufficient acidity for solubilization and minimal tissue irritation upon injection. Higher concentrations would provide better solubilization but cause more stinging at the injection site. Acetic acid is preferred over hydrochloric acid because it is a weak acid that provides buffering capacity, maintaining a more stable pH. Not all peptides require acetic acid reconstitution — most dissolve adequately in bacteriostatic water — so it should only be used when specifically indicated by the peptide manufacturer or when visible precipitation occurs with standard reconstitution.
How is Acetic Acid administered?
Acetic Acid is administered via used to dissolve/reconstitute specific peptides for injection.
What is the half-life of Acetic Acid?
The half-life of Acetic Acid is Not applicable.
Is Acetic Acid legal?
Pharmaceutical-grade sterile acetic acid available through medical supply companies. Not a regulated drug product.